Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Research

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Pain

Microfluidic cancer treatment screen combined with flow cytometry

Is Cancer a Metabolic Disorder?

What Role do Biobanks Play in Cancer Research?

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is Cancer of Unknown Primary?

Targeted Cancer Therapies

Using Biomarkers to Detect Cancer

CDK9 and Cancer

See more featured articles »

Cancer Prevention: Lowering your Risk

Acidosis and Tumor Progression

Investigating the Molecular Mechanisms of Cancer

Cancer Pathophysiology

Insight into Cancer Vaccines

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Pain Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Transforming Cancer Care through Genomic Testing

What is Merkel Cell Carcinoma?

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Symptoms

Effects of Social and Economic Deprivation on Cancer Mortality

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer History

Overview of Cell Viability and Cytotoxicity

Cancer Classification

British Pioneers in Cancer Biology

Assay for Monitoring and Treating Malignant Brain Tumors

Myc Mutations and Cancer

The Effects of Cancer on Family Life

What is Cancer?

Cancer Prognosis

Living with Cancer Pain

Secondary Lung Cancer

Hot vs Cold: the differences between tumor types

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

TARDIS: The Improved Method of Detecting Breast Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Epidemiology

What is Tumorigenesis?

Hypoxia Markers and Their Importance

Cancer Screening Considerations: Balancing the Benefits and Risks

Caring for a Loved One with Cancer

Insights into Oncofertility

Cancer Glossary

The Biochemistry of Breast Cancer Screening

What Causes Cancer?

Cutaneous Manifestations of Internal Malignancy

Secondary Brain Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Pediatric Cancer

What is the Tumor Microenvironment?

Cancer Diagnosis

The Cancer Cell Surface Proteome as a Therapeutic Target

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Immunochemotherapy?

Why are Cancer Cell Lines Useful?

Cancer Management

Latest Cancer News and Research

Childhood cancer survivors face severe mental health challenges as adults

Consultant and researcher Magnus Aasved Hjort believes that people who survive childhood cancer should receive far better support as adults.

28 Sep 2026

New framework maps the complex link between psychological status and cardiovascular health

CVD remains the leading cause of death worldwide, while the global burden of mental disorders continues to rise.

28 Sep 2026

Smart vapes with financial rewards may raise addiction risks

Vaping products are becoming smarter – and potentially more addictive. Some new devices now reward users with cryptocurrency and other incentives tied to vaping behavior.

28 Sep 2026

New EASD study highlights red meat sugar as independent risk factor for type 2 diabetes

Preliminary results of an observational study being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2), reveal that a sugar called dietary N-glycolylneuraminic acid (Neu5Gc), which is common in red meat, is independently associated with a 63% higher risk of developing type 2 diabetes (T2D) in those with the highest versus lowest consumption, even after taking into account other T2D risk factors such as level of physical activity, overall diet, smoking status and other health conditions.

28 Sep 2026

Prostate cancer biology helps identify hormone therapy candidates

A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the PAM50 genomic classifier to determine whether tumor biology could help identify patients most likely to benefit from hormone therapy.

27 Sep 2026

Low-dose radiation shows lasting benefits in patients with knee osteoarthritis

Low-dose radiation therapy may do more than relieve pain from early knee osteoarthritis, with a long-term analysis suggesting it could also influence how the disease progresses.

27 Sep 2026

Long-term endocrine therapy adherence remains low after breast cancer surgery

Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy, a large U.S. insurance claims analysis indicates.

27 Sep 2026

$Hypofractionated radiotherapy for prostate cancer matches conventional treatment outcomes$

Hypofractionated radiotherapy for prostate cancer matches conventional treatment outcomes

Men with high-risk prostate cancer have a higher likelihood of having residual disease following prostatectomy and may require radiation therapy after surgery, particularly when PSA levels begin to rise. Conventional postprostatectomy radiotherapy (COPORT) is typically delivered over 37 fractions, while hypofractionated postprostatectomy radiotherapy (HYPORT) delivers a slightly lower total radiation dose over just 25 fractions.

27 Sep 2026

Ultra-low-dose radiation therapy eases painful bone lesions in multiple myeloma

A short course of ultra-low-dose radiation therapy relieved painful bone lesions from multiple myeloma for most patients in a multi-institutional phase 2 clinical trial.

27 Sep 2026

MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026

Experts from The University of Texas MD Anderson Cancer Center will present nearly 70 abstracts at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.

25 Sep 2026

UCLA researchers present new radiation advances at ASTRO 2026

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial findings at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, including studies on new treatment approaches for prostate, bile duct and head and neck cancers, personalized radiation therapy based on genetic risk, and advances in targeted radiation and radioligand therapy designed to improve cancer control while limiting treatment side effects.

25 Sep 2026

AI-based model predicts glioblastoma recurrence to guide targeted treatment

A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving doctors a chance to treat it before it becomes visible on MRI.

25 Sep 2026

Toxoplasma remodels host cell surfaces to trigger invasion

At first, cholesterol and glycosylation seemed like two separate leads. As the researchers followed them, however, the pathways converged.

25 Sep 2026

UC researcher receives funding to study bone complications in people with sickle cell disease

September is National Sickle Cell Awareness Month, and a University of Cincinnati College of Medicine hematology researcher has received new grant funding to study one of the disease's painful, under-recognized complications: bone damage.

25 Sep 2026

Review highlights emerging treatments for glioblastoma multiforme

A new research perspective was published in Volume 13 of Oncoscience on September 17, 2026, titled "Emerging pharmacological agents for glioblastoma multiforme: An update on active clinical trials (2025–2026)."

25 Sep 2026

Kansas researchers secure NIH funding to fight antibiotic resistance

As antibiotic resistance makes everyday infections tougher to treat and emerging pathogens drive challenging infectious-disease outbreaks, researchers in Kansas from multiple disciplines and institutions are teaming up to target pathogens and overcome antibiotic resistance.

25 Sep 2026

National study benchmarks pancreatic cancer surgery outcomes across China

Pancreatic cancer is among the most aggressive malignancies, and in China it accounts for a substantial and rising share of cancer deaths.

25 Sep 2026

Laser irradiation boosts antibody-antigen interactions to detect colorectal cancer

Researchers often use antibodies to detect specific molecules or biological markers, as they are remarkably precise at recognizing their targets.

25 Sep 2026

New project aims to make cellular therapies more accessible through room temperature storage

The Advanced Research Projects Agency for Health, or ARPA-H, has executed an award of up to $36.5 million in support of a University of California, Davis-led project aiming to make cellular therapies cheaper and more accessible through room temperature storage.

25 Sep 2026

Researchers find how prostate tumors reshape the immune microenvironment

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment to resist treatment.

25 Sep 2026